Observational studyBMC anesthesiology2026
Comparison of clinical performance among the I-Gel Proseal Lma and Tulip Oropharyngeal Airway.
Observational study in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSupraglottic airway (SGA) devices are widely used to facilitate ventilation during general anesthesia. However, comparative clinical data on different SGA designs remain limited. This study aimed to compare the placement characteristics, clinical performance, and complication profiles of three SGA devices: I-Gel™, the ProSeal™ LMA, and Tulip® Oropharyngeal Airway.
methodsThis prospective, observational study included 135 adult patients (ASA I–III) scheduled for elective surgery. Three patients were excluded before device placement, leaving 132 patients for analysis. Device selection was based on routine clinical judgment. Failed placements (n = 17) were included in the analysis of placement success and failure rates but excluded from performance-related outcomes such as insertion time and ease of insertion. The primary outcome was insertion time. Secondary outcomes included number of attempts, need for additional maneuvers, hemodynamic parameters, and perioperative complications.
resultsAmong 132 evaluated placements, the Tulip device demonstrated a significantly higher failure rate compared with I-Gel and ProSeal (25% vs. 5% and 5%, respectively; p = 0.004). Consequently, performance outcomes were analyzed in 115 successfully ventilated patients (I-Gel n = 38, ProSeal n = 38, Tulip n = 39). The Tulip group required a greater number of insertion attempts (p = 0.002). No significant differences were observed between the groups regarding insertion time, ease of insertion, need for maneuvers, hemodynamic variables, or adverse events (p > 0.05).
conclusionWhile ProSeal and I-Gel showed comparable clinical performance, the Tulip airway was associated with a higher rate of unsuccessful placement and required more insertion attempts. These findings suggest that device design and operator familiarity may influence placement success. Larger randomized studies are warranted to confirm these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.